Tuberculosis Research Unit

The Tuberculosis Unit (UTB) was founded on 2004.  It was stablished as a space where IMT AvH workers that were currently working on tuberculosis research could assemble and collaborate on their activities.

Since its beginnings, UTB has managed to successfully develop research on epidemiology, diagnostic and treatment on tuberculosis. UTB has participated on several researches of international relevance as an example of this, studies on GeneXpert, MTB/RIF took place in the unit.  On the other hand research on basic science, immunology and cost effectiveness have also taken place on the UTB.

UTB has gather a multidisciplinary team that has achieved to build good relationships with institutions on local, national and international level to work together against tuberculosis.


Research interest

• Diagnostic Methods

• Clinical Trials
• Operational Research
• Qualitative Research
• Systematic reviews / meta-analysis
• Immunology
• Molecular Epidemiology



Group Coordinator:

seas  Carlos Seas, MD

 Research team:

  • Eduardo Gotuzzo, MD
  • Jessica Ricaldi, MD, Ph.D.
  • Carlos Zamudio, MD.
  • Larissa Otero, MD, MPH
  • César Ugarte, MD, MsC
  • Juan Agapito, MSc.
  • Lic. Tatiana Cáceres
  • Francesca Capanni,  MD
  • Mateo Prochazka, MD
  • Jimena Collantes.
  • Juana Sedamano, MD
  • Francesca Barletta
  • Lena Shah

Colaboration and Fundings

Recent Projects

  • Matrix Metalloproteinases Degradation Products And Their Correlation With TB , TB / Diabetes Mellitus And TB / HIV
  • Cohort Study:  Patients with Pulmonary Tuberculosis.
  • Improving the diagnosis of childhood tuberculosis; Validation of new biomarkers in an environment of high prevalence.
  • Prospective, Randomized, Blinded Phase 2 Pharmacokinetic/Pharmacodynamic Study of the Efficacy and Tolerability of Levofloxacin in Combination with Optimized Background Regimen (OBR) for the treatment of MDR-TB
  • Active search of household contacts of TB cases in high-risk area in Lima, Peru.
  • Multicenter study.  Crossectional to determine the ability to improve the diagnosis of TB in a multiplex serology test at the point of care study.
  • Evaluation of a Treatment Scheme Rifapentine for the intensive phase of treatment of pulmonary tuberculosis.
  • major depressive disorder as a risk factor for Successful changes in the outcome of TB treatment.
  • Study of Contacts Residential TB.
  • Research household contacts of children under five years of BK positive TB patients in Lima, Peru.

Relevant Publications


TBC rapid diagnostic Methods:                                       

GeneXpertTM MTB/Rif (GX)
Mycobacteria Growth Indicator Tube (MGIT)

TBC Cultures:




Contact Info


Address: IMTAvH, 1er piso

Hospital Nacional Cayetano Heredia

Av. Honorio Delgado 262

Urb. Ingeniería, San Martin de Porres. Lima - Perú.



  • 51-1- 613-9797 anexo 4033
  • 51-1-791-2471
  • 51-1- 628-2517

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.